Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy (Q40873316)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy
scientific article

    Statements

    Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy (English)
    1 February 1993
    3 Suppl
    1059-1067

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit